The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 21 results:
Author Title [ Type(Desc)] Year
Filters: Author is Katopodi, Theodora  [Clear All Filters]
Journal Article
Anastasopoulos, E., Coleman A. L., M Wilson R., Sinsheimer J. S., Yu F., Katafigiotis S., et al. (2014).  Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study.. Invest Ophthalmol Vis Sci. 55(7), 4238-43.
Dimitrakopoulos, I., Psomaderis K., Katopodi T., Iordanidis F., & Georgoulis I. (2007).  Burkitt's lymphoma with loss of the long arm of chromosome 1.. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 103(5), e42-7.
Anestakis, D., Petanidis S., Domvri K., Tsavlis D., Zarogoulidis P., & Katopodi T. (2020).  Carboplatin chemoresistance is associated with CD11b/Ly6C myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells.. Mol Immunol. 118, 99-109.
Ntelios, D., Efthimiadis G., Zegkos T., Didagelos M., Katopodi T., Meditskou S., et al. (2020).  Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy.. Hellenic J Cardiol.
Ntelios, D., Efthimiadis G., Zegkos T., Didagelos M., Katopodi T., Meditskou S., et al. (2020).  Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy. Hellenic Journal of Cardiology.
Domvri, K., Petanidis S., Anestakis D., Porpodis K., Bai C., Zarogoulidis P., et al. (2020).  Dual photothermal MDSCs-targeted immunotherapy inhibits lung immunosuppressive metastasis by enhancing T-cell recruitment.. Nanoscale. 12(13), 7051-7062.
Katopodi, T., Petanidis S., Tsavlis D., Anestakis D., Charalampidis C., Chatziprodromidou I., et al. (2022).  Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy.. Front Oncol. 12, 1042125.
Gougousis, S., Petanidis S., Poutoglidis A., Tsetsos N., Vrochidis P., Skoumpas I., et al. (2022).  Epigenetic editing and tumor-dependent immunosuppressive signaling in head and neck malignancies.. Oncol Lett. 23(6), 196.
Domvri, K., Petanidis S., Anestakis D., Porpodis K., Bai C., Zarogoulidis P., et al. (2020).  Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance via immunosuppressive miR-182/miR-217 signaling and p27/CDK6 regulation.. Oncotarget. 11(29), 2847-2862.
Lazaridou, M. Nikolaou, Katopodi T., & Dimitrakopoulos I. (2015).  Gorlin-Goltz syndrome: a 25-year follow-up of a familial case.. Oral Maxillofac Surg. 19(1), 79-84.
Chatziprodromidou, I. P., Dimitrakopoulou M-E., Apostolou T., Katopodi T., Charalambous E., & Vantarakis A. (2022).  Hepatitis A and E in the Mediterranean: A systematic review.. Travel Med Infect Dis. 47, 102283.
Katopodi, T., Petanidis S., Grigoriadou E., Anestakis D., Charalampidis C., Chatziprodromidou I., et al. (2024).  Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy.. Pharmaceutics. 16(4), 
Katopodi, T., Petanidis S., Anestakis D., Charalampidis C., Chatziprodromidou I., Floros G., et al. (2023).  Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery.. Pharmaceutics. 15(10), 
Katopodi, T., Petanidis S., Domvri K., Zarogoulidis P., Anestakis D., Charalampidis C., et al. (2021).  Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit.. Sci Rep. 11(1), 15455.
Dimitrakopoulos, I., Magopoulos C., & Katopodi T. (2007).  Mandibular osteomyelitis in a patient with pyknodysostosis: a case report of a 50-year misdiagnosis.. J Oral Maxillofac Surg. 65(3), 580-5.
Tsavlis, D., Katopodi T., Anestakis D., Petanidis S., Charalampidis C., Chatzifotiou E., et al. (2022).  Molecular and Immune Phenotypic Modifications during Metastatic Dissemination in Lung Carcinogenesis.. Cancers (Basel). 14(15), 
Kouidou, S., Agidou T., Kyrkou A., Andreou A., Katopodi T., Georgiou E., et al. (2005).  Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.. Lung Cancer. 50(3), 299-307.
Demirtzoglou, G., Chrysoglou S-I., Katopodi T., Dimitroulas T., Iakovidou-Kritsi Z., Garyfallos A., et al. (2023).  Olanzapine's Cytogenetic Effect on T Lymphocytes in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients: In Vitro Study.. Cureus. 15(4), e37683.
Domvri, K., Petanidis S., Zarogoulidis P., Anestakis D., Tsavlis D., Bai C., et al. (2021).  Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis.. Clin Immunol. 222, 108620.
Katopodi, T., Petanidis S., Anestakis D., Charalampidis C., Chatziprodromidou I., Floros G., et al. (2023).  Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization.. Front Immunol. 14, 1325360.
Katopodi, T., Petanidis S., Charalampidis C., Chatziprodromidou I., Eskitzis P., Tsavlis D., et al. (2022).  Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance.. Cells. 11(20), 

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.